retatrutide parkinson clinical trial 💊 There's a new once-daily #Parkinsons #drug nearing FDA decision. @abbvie's Retatrutide vs Eloralintide Obesity Therapies

There was an 18% lower risk of major cardiovascular events with semaglutide compared to placebo (212 vs 254

Additionally, patient preference for medications with dual benefits of glucose control and weight management is strengthening demand for GLP-1 therapies across global healthcare systems

490 Recently, it has been demonstrated that zinc-induced cardiac endogenous antioxidant MT blocks TRB3 induction, thereby preserving Akt2 signaling and preventing DCM

However, several adult studies are showing that IF may lead to significant reduction of steatosis, liver enzymes and fibrosis when assessed by MRI, for liver elastography or Fibroscan [[100], [101], [102], [103], [104], [105], [106], [107]]